Digital Content 
NEWS #PharmaBuzz
31 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-presents-new-data-at-psych-congress-2024-confirming-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-treatment-benefits-in-narcolepsy-and-idiopathic-hypersomnia-302293081.html
24 Jul 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-24-2024-12306.pdf
01 Jun 2022
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf
03 Jan 2022
// BIOSPACE
https://www.biospace.com/article/releases/u-s-fda-grants-orphan-drug-exclusivity-ode-for-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-idiopathic-hypersomnia-in-adults/
https://www.pharmacompass.com/pdf/news/health-canada-issue-recalls-of-canprev-natural-health-productss-magnesium-bisglycinate-powder-250-rose-hip-dragonfruit-1620794876.pdf
20 Oct 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-sleep-publication-of-phase-3-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-study-in-cataplexy-or-excessive-daytime-sleepiness-in-patients-with-narcolepsy-301155706.html
LOOKING FOR A SUPPLIER?
Share